The world of pet care has been on a continuous transformation and pet parents have come a long way from taking their companion animals to regular check-ups and vaccinations to getting them fancy diet food and wearables. Companion animal health has thus been garnering a lot of attention worldwide. With rising pet population, and expanding pet culture, global companion animal health market is expected to witness a healthy growth outlook in future. A new Fairfield Market Research study states that the market for companion animal health will exhibit notable progress in long term, with the rate of pet ownership seeing a marked rise. Favourable government initiatives taken toward raising the awareness about animal health and welfare will further catalyse market growth, says the report. For More Information of Companion Animal Health Market Visit: https://www.fairfieldmarketresearch.com/report/companion-animal-health-market
Increase in burden of cancer globally, growing demand for personalized medicine and targeted therapy coupled with increase in adoption of drug diagnostics co-development model by industry players are the key factors driving the global companion diagnostics market.
Rise in prominence of personalized medicine, surge in cases of adverse drug reactions, and advancements in technologies for diagnostic techniques drive the growth in the global companion diagnostics market.
Research Nester released a report titled “Companion Animal Diagnostics Market: Global Demand Analysis & Opportunity Outlook 2029” which delivers detailed overview of the global companion animal diagnostics market in terms of market segmentation by technology, application, animal type, end-user and region.
As per Roche’s Personalized Healthcare Brochure, for every 10 patients with cancer treated, only an average of half will actually benefit from it. Read more: https://inkwoodresearch.com/companion-diagnostics-market-relevant-developments-overview/
Medical treatments are typically designed using uniform patterns, with patients with the same disease. Get more insights into the Companion Diagnostic market.
The global companion diagnostics market is anticipated to grow at a CAGR of 13.29%, and is estimated to reach $15441.90 million by 2030. Get Free Sample Report.
This report, from Stratview Research, studies the global clinical diagnostics market - companion diagnostics over the trend period of 2014 to 2017 and forecast period of 2018 to 2025.
Global Market Insights Inc. Add New Report Global Next Generation Sequencing Market to its database which covers the market landscape and its growth prospects over the coming years.
Cancer Diagnostics Global Market Report 2020 is the latest research report added to The Business Research Company database. The report is covered in 200 pages covering 5 major players in the industry.
According to the latest research report by IMARC Group, The global companion diagnostics market size reached US$ 5.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 11.7 Billion by 2027, exhibiting a growth rate (CAGR) of 14.78% during 2022-2027. More Info:- https://www.imarcgroup.com/companion-diagnostics-market
Global Molecular Diagnostics Market is estimated to value over USD 12.6 billion by 2026 end and register a CAGR of over 8.9% during the forecast period 2019 to 2026.
Stay up-to-date with latest Insights of Companion Diagnostic market research offered by Allied Market Research. Check how key trends and emerging drivers are shaping this industry growth.
Looking forward, the companion diagnostics market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/companion-diagnostics-market
The Business Research Company’s Cancer Diagnostics Global Market Report 2019 covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. http://bit.ly/2lVsMXp
he global market for veterinary diagnostic is estimated to progress at 7.71% CAGR throughout 2019-2027 and will generate revenue of $5,129 million by the end of 2027. The heavy demand for livestock products is partly responsible for the steady increase in market growth over the years.Know more @ https://www.inkwoodresearch.com/reports/north-america-veterinary-diagnostics-market/
Research Beam added report on “Global Veterinary Diagnostics Market Outlook 2015 – 2022”. The Global Veterinary Diagnostics Market is estimated to be $2.8 billion in 2014 and is poised to reach $5.9 billion by 2022, growing at a CAGR of 9.8% from 2014 to 2022. Enquiry @ http://www.researchbeam.com/global-veterinary-diagnostics-outlook-2014-2022-market/enquire-about-report
The global companion diagnostics market is anticipated to grow at a CAGR of 13.29%, and is estimated to reach $15441.90 million by 2030. Get Free Sample Report.
The report "Companion Diagnostics Market by Product (Assays, Kits, Software & Services), Technology (PCR, NGS, ISH, IHC), Indication (Breast, Blood, Lung, Colorectal Cancer, Neurology Diseases), End User (Pharma Companies, CROs), Region - Global Forecast to 2026", the global companion diagnostics market is projected to reach USD 9.9 billion by 2026 from USD 5.5 billion in 2021, at a CAGR of 12.6%.
Big Market Research “Global Veterinary Diagnostics Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2022. Visit for more info @ http://www.bigmarketresearch.com/global-veterinary-diagnostics-outlook-2014-2022-market The report titled “Global Veterinary Diagnostics Market Outlook (2014-2022)” is an outcome of an in-depth market analysis, with the help of valuable inputs from industry experts. The report offers rational explanations for market dynamics along with detailed market estimations. The veterinary diagnostics market was evaluated at $2.8 billion in the year 2014 and would reach $5.9 billion by 2022, registering 9.8% CAGR during 2014-2022.
Global Veterinary Diagnostics Market was valued at USD 2.6 Billion in 2021 and is expected to reach USD 5.01 Billion by 2029, registering a CAGR of 8.55% during the forecast period of 2022-2029. https://www.databridgemarketresearch.com/reports/global-veterinary-diagnostics-market
According to the latest research report by IMARC Group, The global veterinary diagnostics market size reached US$ 6.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.6 Billion by 2032, exhibiting a growth rate (CAGR) of 7.3% during 2024-2032. More Info:- https://www.imarcgroup.com/veterinary-diagnostics-market
Molecular diagnostics, a rapidly evolving segment of the healthcare industry, utilizes molecular biology techniques to analyze biological markers at the molecular level. This approach enables precise detection, diagnosis, and monitoring of various diseases, leading to personalized treatment strategies and improved patient outcomes. The global molecular diagnostics market demonstrates robust growth, driven by technological advancements, increasing prevalence of infectious diseases and cancer, and growing demand for rapid and accurate diagnostic solutions. The global molecular diagnostics market is forecast to expand at a CAGR of 6.2% and thereby increase from a value of US$23.2 Bn in 2024, to US$35.6 Bn by the end of 2031.
Market Overview: Cancer Tissue Diagnostics Market Cancer tissue diagnostics play a pivotal role in oncology by facilitating accurate diagnosis, prognosis, and treatment selection based on tissue samples obtained from patients. The global cancer tissue diagnostics market is witnessing steady growth, driven by the increasing incidence of cancer, advancements in diagnostic technologies, and growing emphasis on personalized medicine.
In Vitro Diagnostics Market USD 102.18 billion in 2024, poised for significant growth to USD 131.66 billion by 2029, with a notable CAGR of 5.20%. The catalyst for this growth is the global response to the COVID-19 pandemic.
According to the latest research report by IMARC Group, The global veterinary molecular diagnostics market size reached US$ 690.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,391.9 Million by 2032, exhibiting a growth rate (CAGR) of 7.9% during 2024-2032. More Info:- https://www.imarcgroup.com/veterinary-molecular-diagnostics-market
The Global Molecular Diagnostics Market is expected to attain a market size of $11.2 billion by 2022, growing at a CAGR of 8.6% during the forecast period. Full report: http://kbvresearch.com/global-molecular-diagnostics-market/
The Business Research Company offers veterinary infectious disease diagnostics market research report 2023 with industry size, share, segments and market growth
The global veterinary molecular diagnostics market is primarily driven by the widespread prevalence of zoonotic diseases and the surging pet ownership rates. Additionally, the growing animal husbandry activities and the rising concerns regarding food safety have augmented the product demand. Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: Visit the following link: https://www.imarcgroup.com/veterinary-molecular-diagnostics-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099
Cancer diagnostic devices are used to diagnose the stage and cause of the condition by identifying the oncogenic proteins, and certain enzymes released by the tumor cells in patients. The main products in cancer diagnostics are companion diagnostics and molecular diagnostics. Molecular diagnostics is a laboratory method that is used to check for certain proteins, genes, or other molecules that may be a sign of cancer. The methods used in cancer diagnostics are biopsy, endoscopy, tumor biomarker tests, and imaging. The applications covered in cancer diagnostics are cervical cancer, breast cancer, liver cancer, blood cancer, kidney cancer, colorectal cancer, pancreatic cancer, ovarian cancer, melanoma, and others that are used by end-users such as cancer research institutes, diagnostic laboratories, hospitals, and others.
Veterinary Endoscopy Market is projected to grow from USD 170.2 million in 2020 to USD 238.7 million by 2026 at a CAGR of over 5.8% during the forecast period. Read More at https://www.stratviewresearch.com/1701/veterinary-endoscopy-market.html
The report provides a detailed understanding and analysis of how and why companies enter companion diagnostic partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors companion diagnostics technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
According to the latest research report by IMARC Group, The global veterinary molecular diagnostics market size reached US$ 634.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,064.8 Million by 2028, exhibiting a growth rate (CAGR) of 8.8% during 2023-2028. More Info:- https://www.imarcgroup.com/veterinary-molecular-diagnostics-market
The global veterinary infectious disease diagnostics market size was USD 1.70 Billion in 2021 and is expected to register a revenue CAGR of 9.1% during the forecast period, according to the latest analysis by Emergen Research. Revenue growth of the veterinary infectious disease diagnostics market is driven by factors such as rising number of veterinary practitioners in developed countries, increasing prevalence of transboundary & zoonotic disease, and rising demand for pet insurance, advanced diagnostic devices, companion animal, and animal-derived food products.
Global Radiopharmaceutical Theragnostics Market Forecast to 2028 – COVID-19 Impact and Analysis – by Product Type, Radioisotope, Source, Application, Indication, and End User,” the market is expected to grow from US$ 1,814.58 million in 2022 to US$ 3,441.97 million by 2028; it is estimated to grow at a CAGR of 11.3% from 2022 to 2028
Companion diagnostics are a form of in-vitro diagnostics which provide data about the therapeutic reactions of patients for a particular treatment. Companion diagnostics market is still developing, and it is expected to reach a market value of $3.5 billion by 2020 from a market value of $1.1 billion in the year 2013, registering a CAGR of 20% during 2014-2020.
Companion diagnostics can allow for a specific patient population to be identified which will ensure those patients who are most likely to respond are recruited for clinical trials and receive the therapy once the product is launched. Companion diagnostics can help to rationalize treatment decisions, with specifics such as accurate dosing, risks of adverse events and diagnostics being made possible through these tests. Through the use of companion diagnostics, the right treatment can be delivered to the right patient at the right time, delivering greater value and optimizing healthcare resource utilization
This report describes the current technologies that are propelling the personalized medicine and companion diagnostic market. It examines the current genetic diagnostic tests and companion diagnostic assays that are in use by the medical and pharmaceutical industry today. Current developments in personalized medicine and the pharmacogenomics revolution are discussed.
Get more details @ http://bit.ly/2l3rNQ4 Key industry players contributing to global precision medicine market share include Pfizer, Roche, Covance, Novartis, Qiagen, Biocrates Life Sciences, Teva Pharmaceutical, Nanostring Technologies, Laboratory Corporation of America Holdings, Tepnel Pharma Services, Intomics, Ferrer InCode, Silicon Biosystems, Eagle Genomics, Medtronic, and Quest Diagnostics
The new Companion Animal Diagnostic Market report offers a comprehensive study of the present scenario of the market coupled with major market dynamic. Also, it highlights the in-depth market analysis with the latest trends, drivers and its segments with respect to regional and country. Further, this report profiles top key players of the companion animal diagnostic and analyze their market share, strategic development and other development across the globe.
The molecular diagnostics market is expected to grow at a CAGR of 9.3% to reach USD 9,333.8 Million by 2020. High prevalence of infectious diseases and various types of cancer; increasing awareness and acceptance of personalized medicine and companion diagnostics; development of biomarkers; and advancements in molecular techniques, proteomics, and reformations in the reimbursement system are driving the growth of the market.
In IVD market oncology is one of the most sought-after segments by the manufacturers. Non-invasive cancer testing is expected to be a hot market in 2019. Qiagen, one of the global MNC, has been pioneering the use of liquid biopsy-based companion diagnostics as a less-invasive option to complement surgical biopsies for genomic profiling of cancers.
[320 Pages Report] Tissue Diagnostics Market report categories the Global market by Technology (Digital pathology & Workflow, Immunohistochemistry, in Situ Hybridization, Special Staining), Disease (Breast Cancer, Lymphoma, Gastric Cancer, Non Small Cell Lung Cancer , Prostate Cancer and Others), Product, End-Users & by Region (The Americas, Europe, BRIC, Japan & RoW)
Equine Veterinary Therapeutics Market report segmented the market by product types, route of administration, distribution channels & geography with in-depth analysis on revenue, trends, growth, share, size & forecast to 2022.
The major players in the precision medicine market are Qiagen, Novartis AG, Medtronic, AstraZeneca plc., Quest Diagnostics, Thermo Fisher Scientific Inc...@@ https://bit.ly/2XCz1CE
The global precision medicine market is expected to grow from $62.75 billion in 2020 to $72.58 billion in 2021 at a compound annual growth rate (CAGR) of 15.7%.
Bharat Book presents the report on “Global Markets for Animal Therapeutics and Diagnostics” (https://www.bharatbook.com/healthcare-market-research-reports-315995/global-animal-therapeutics-diagnostics.html). This report, Global Markets for Animal Therapeutics and Diagnostics, provides an overview of products included in this market and detailed market analyses and competitive environments.